A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

NCT06149559 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

DRUG: rozanolixizumab

Sponsor

UCB Biopharma SRL